{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:43:52Z","timestamp":1780487032318,"version":"3.54.1"},"reference-count":22,"publisher":"Societas Neurologica Japonica","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2026]]},"DOI":"10.5692\/clinicalneurol.cn-002145","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:08:59Z","timestamp":1773180539000},"page":"249-255","source":"Crossref","is-referenced-by-count":1,"title":["Febrile infection-related epilepsy syndrome (FIRES) with the claustrum sign in a 55-year-old woman: a case report","Claustrum sign\u3092\u5448\u3057\u305ffebrile infection related epilepsy syndrome\uff08FIRES\uff09\u306e55\u6b73\u5973\u6027\u4f8b"],"prefix":"10.5692","volume":"66","author":[{"given":"Go","family":"Akao","sequence":"first","affiliation":[{"name":"Division of Neurology, Tohoku Medical and Pharmaceutical University"},{"name":"Department of Neurology, NHO Sendai Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Division of Neurology, Tohoku Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juichi","family":"Fujimori","sequence":"additional","affiliation":[{"name":"Division of Neurology, Tohoku Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Division of Neurology, Tohoku Medical and Pharmaceutical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia 2018;59:739-744.","DOI":"10.1111\/epi.14016"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) \u4e2d\u7530\u907c\u5fd7\uff0c\u5bfa\u6fa4\u7531\u4f73\uff0c\u4f50\u85e4\u5065\u3089\uff0e\u75c5\u521d\u671f\u306e\u767a\u4f5c\u983b\u5ea6\u5897\u52a0\u306b\u4f34\u3044\u9ac4\u6db2IL-6\u4e0a\u6607\u3092\u8a8d\u3081\u305fcryptogenic new-onset refractory status epilepticus\uff08NORSE\uff09\u306e1\u4f8b\uff0e\u81e8\u5e8a\u795e\u7d4c 2023;63:843-846.","DOI":"10.5692\/clinicalneurol.cn-001879"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Gaspard N, Hirsch LJ, Sculier C, et al. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia 2018;59:745-752.","DOI":"10.1111\/epi.14022"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sculier C, Gaspard N. New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Curr Opin Neurol 2023;36:110-116.","DOI":"10.1097\/WCO.0000000000001137"},{"key":"5","unstructured":"5) \u300c\u3066\u3093\u304b\u3093\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u300d\u4f5c\u6210\u59d4\u54e1\u4f1a \uff0e\u3066\u3093\u304b\u3093\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32018\uff0e\u6771\u4eac\uff1a\u533b\u5b66\u66f8\u9662\uff1b2018\uff0ep. 76-88."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hirsch LJ, Fong MWK, Leitinger M, et al. American Clinical Neurophysiology Society\u2019s Standardized Critical Care EEG Terminology: 2021 Version. J Clin Neurophysiol 2021;38:1-29.","DOI":"10.1097\/WNP.0000000000000806"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Carson R, Stredny CM. Severe, Refractory seizures: new-onset refractory status epilepticus and febrile infection-related epilepsy syndrome. Med Clin North Am 2024;108:201-213.","DOI":"10.1016\/j.mcna.2023.05.020"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lattanzi S, Leitinger M, Rocchi C, et al. Unraveling the enigma of new-onset refractory status epilepticus: a systematic review of aetiologies. Eur J Neurol 2022;29:626-647.","DOI":"10.1111\/ene.15149"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016;15:391-404.","DOI":"10.1016\/S1474-4422(15)00401-9"},{"key":"10","unstructured":"10) \u5c0f\u5150\u6025\u6027\u8133\u75c7\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u6539\u8a02\u30ef\u30fc\u30ad\u30f3\u30b0\u30b0\u30eb\u30fc\u30d7\u7de8\uff0e\u5c0f\u5150\u6025\u6027\u8133\u75c7\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f32023\uff0e\u6771\u4eac\uff1a\u8a3a\u65ad\u3068\u6cbb\u7642\u793e\uff1b2023. p. 8-11."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Lai X, Jin L, Zhou Y, et al. Safety evaluation of baloxavir marboxil: analysis and discussion utilizing real adverse events from the FAERS database. BMC Pharmacol Toxicol 2025;26:110.","DOI":"10.1186\/s40360-025-00940-0"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Meletti S, Giovannini G, d\u2019Orsi G, et al. New-onset refractory status epilepticus with claustrum damage: definition of the clinical and neuroimaging features. Front Neurol 2017;8:111.","DOI":"10.3389\/fneur.2017.00111"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Culleton S, Talenti G, Kaliakatsos M, et al. The spectrum of neuroimaging findings in febrile infection-related epilepsy syn\u00addrome (FIRES): a literature review. Epilepsia 2019;60:585-592.","DOI":"10.1111\/epi.14684"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Gaspard N, Foreman BP, Alvarez V, et al. New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology 2015;85:1604-1613.","DOI":"10.1212\/WNL.0000000000001940"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Kim HJ, Lee SA, Kim HW, et al. The timelines of MRI findings related to outcomes in adult patients with new-onset refractory status epilepticus. Epilepsia 2020;61:1735-1748.","DOI":"10.1111\/epi.16620"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Gugger JJ, Husari K, Probasco JC, et al. New-onset refractory status epilepticus: a retrospective cohort study. Seizure 2020;74:41-48.","DOI":"10.1016\/j.seizure.2019.12.002"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Silva G, Jacob S, Melo C, et al. Claustrum sign in a child with refractory status epilepticus after febrile illness: why does it happen? Acta Neurol Belg 2018;118:303-305.","DOI":"10.1007\/s13760-017-0820-9"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) \u732a\u5965\u5fb9\u4e5f\uff0c\u4e95\u4e0a\u5cb3\u53f8\uff0c\u4e5d\u9b3c\u4e00\u90ce\u3089\uff0e\u9577\u671f\u9593\u306e\u96c6\u4e2d\u6cbb\u7642\u7ba1\u7406\u3092\u8981\u3057\u305ffebrile infection-related epilepsy syndrome\u306e1\u4f8b\uff1a\u30b1\u30bf\u30df\u30f3\u6301\u7d9a\u9759\u6ce8\uff0c\u30c7\u30ad\u30b5\u30e1\u30bf\u30be\u30f3\u9ac4\u8154\u5185\u6295\u4e0e\u306e\u8a66\u307f\uff0e\u81e8\u5e8a\u795e\u7d4c 2022;62:123-129.","DOI":"10.5692\/clinicalneurol.cn-001624"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Basso M, Gastaldi M, Leonardi V, et al. Connections between febrile infection-related epilepsy syndrome and autoimmune encephalitis. A case report of a child with new anti-neuronal antibodies. Front Pediatr 2022;10:908518.","DOI":"10.3389\/fped.2022.908518"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Guo K, Hong Z. Claustrum sign in febrile infection-related epilepsy syndrome (FIRES). Neurol Sci 2023;44:3357-3359.","DOI":"10.1007\/s10072-023-06887-6"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Konomatsu K, Kakisaka Y, Jin K, et al. Adult-onset epilepsy with startle-induced seizure after febrile infection-related epilepsy syndrome: a case report. Epileptic Disord 2025;27:451-456.","DOI":"10.1002\/epd2.70026"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Iizuka T, Kanazawa N, Kaneko J, et al. Cryptogenic NORSE: its distinctive clinical features and response to immunotherapy. Neurol Neuroimmunol Neuroinflamm 2017;4:e396.","DOI":"10.1212\/NXI.0000000000000396"}],"container-title":["Rinsho Shinkeigaku"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/66\/4\/66_cn-002145\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T03:44:17Z","timestamp":1777088657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/66\/4\/66_cn-002145\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.cn-002145","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"cn-002145"}}